Landaas & Company’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $497K | Buy |
1,372
+272
| +25% | +$93.1K | 0.09% | 81 |
|
|
2026
Q1 | $387K | Hold |
1,100
| – | – | 0.08% | 84 |
|
|
2025
Q4 | $360K | Hold |
1,100
| – | – | 0.08% | 85 |
|
|
2025
Q3 | $310K | Hold |
1,100
| – | – | 0.07% | 85 |
|
|
2025
Q2 | $307K | Hold |
1,100
| – | – | 0.07% | 84 |
|
|
2025
Q1 | $343K | Hold |
1,100
| – | – | 0.09% | 58 |
|
|
2024
Q4 | $287K | Sell |
1,100
-27
| -2% | -$8.01K | 0.08% | 65 |
|
|
2024
Q3 | $363K | Hold |
1,127
| – | – | 0.1% | 49 |
|
|
2024
Q2 | $352K | Sell |
1,127
-623
| -36% | -$183K | 0.11% | 50 |
|
|
2024
Q1 | $498K | Hold |
1,750
| – | – | 0.16% | 34 |
|
|
2023
Q4 | $504K | Sell |
1,750
-40
| -2% | -$10.9K | 0.19% | 34 |
|
|
2023
Q3 | $481K | Hold |
1,790
| – | – | 0.21% | 33 |
|
|
2023
Q2 | $397K | Hold |
1,790
| – | – | 0.18% | 37 |
|
|
2023
Q1 | $433K | Hold |
1,790
| – | – | 0.21% | 36 |
|
|
2022
Q4 | $470K | Hold |
1,790
| – | – | 0.26% | 28 |
|
|
2022
Q3 | $403K | Hold |
1,790
| – | – | 0.26% | 29 |
|
|
2022
Q2 | $436K | Sell |
1,790
-277
| -13% | -$67.9K | 0.27% | 30 |
|
|
2022
Q1 | $465K | Hold |
2,067
| – | – | 0.25% | 38 |
|
|
2021
Q4 | $465K | Hold |
2,067
| – | – | 0.25% | 38 |
|
|
2021
Q3 | $440K | Buy |
2,067
+28
| +1% | +$6.45K | 0.25% | 37 |
|
|
2021
Q2 | $497K | Hold |
2,039
| – | – | 0.28% | 37 |
|
|
2021
Q1 | $507K | Buy |
2,039
+595
| +41% | +$142K | 0.3% | 35 |
|
|
2020
Q4 | $332K | Sell |
1,444
-200
| -12% | -$46.1K | 0.23% | 41 |
|
|
2020
Q3 | $418K | Hold |
1,644
| – | – | 0.32% | 34 |
|
|
2020
Q2 | $388K | Buy |
+1,644
| New | +$375K | 0.31% | 33 |
|
|
2020
Q1 | – | Sell |
-1,644
| Closed | -$396K | – | 51 |
|
|
2019
Q4 | $396K | Hold |
1,644
| – | – | 0.28% | 34 |
|
|
2019
Q3 | $318K | Sell |
1,644
-52
| -3% | -$9.98K | 0.23% | 42 |
|
|
2019
Q2 | $313K | Sell |
1,696
-5,147
| -75% | -$922K | 0.22% | 42 |
|
|
2019
Q1 | $322K | Buy |
6,843
+5,098
| +292% | +$974K | 0.23% | 41 |
|
|
2018
Q4 | $340K | Hold |
1,745
| – | – | 0.28% | 37 |
|
|
2018
Q3 | $362K | Hold |
1,745
| – | – | 0.28% | 39 |
|
|
2018
Q2 | $322K | Hold |
1,745
| – | – | 0.26% | 39 |
|
|
2018
Q1 | $297K | Buy |
1,745
+40
| +2% | +$7.34K | 0.3% | 39 |
|
|
2017
Q4 | $296K | Hold |
1,705
| – | – | 0.26% | 39 |
|
|
2017
Q3 | $318K | Buy |
+1,705
| New | +$302K | 0.28% | 41 |
|
Other funds holding AMGN
Landaas & Company's AMGN Position: Q2 2026 in Review
Landaas & Company increased its Amgen (AMGN) stake by 25% in Q2 2026, buying an estimated $93.1K and bringing the position to 1,372 shares worth $497K. The position accounts for 0.09% of the portfolio, ranked #81.
Landaas & Company first reported a position in AMGN in Q3 2017 and has held it in 35 quarters since. The position peaked at $507K in Q1 2021. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Landaas & Company held 1,372 shares of Amgen worth $497K as of Q2 2026.
- Landaas & Company bought 272 Amgen shares in Q2 2026, an estimated $93.1K.
- Amgen made up 0.09% of Landaas & Company's portfolio in Q2 2026, its #81 holding.
- Landaas & Company first reported a position in Amgen in Q3 2017 and has held it in 35 quarters since.
- Landaas & Company's Amgen position peaked at $507K in Q1 2021.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Landaas & Company's 13F filing for Q2 2026, filed 21 Jul 2026.